The methenamine hippurate tablets global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Methenamine Hippurate Tablets Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size —
The methenamine hippurate tablets market size has grown strongly in recent years. It will grow from $8.97 billion in 2023 to $9.63 billion in 2024 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to traditional uti treatment, antibiotic resistance concerns, clinical validation, physician prescription patterns, patient preference for non-antibiotic solutions.
The methenamine hippurate tablets market size is expected to see strong growth in the next few years. It will grow to $12.83 billion in 2028 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to growing uti prevalence, rising antibiotic resistance concerns, advancements in uti management, healthcare focus on preventive therapies,clinical trials and research. Major trends in the forecast period include increased uti incidence, rising antibiotic resistance, preference for non-antibiotic treatments, focus on preventive healthcare, research and development.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/methenamine-hippurate-tablets-global-market-report
Scope Of Methenamine Hippurate Tablets Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Methenamine Hippurate Tablets Market Overview
Market Drivers –
An increasing geriatric population is expected to boost the growth of the methenamine hippurate tablets market going forward. Geriatric population refers to the population of older people of 60 years and above. Geriatric patients are more vulnerable to urinary tract infections due to a variety of factors such as decreased urine flow, an enlarged prostate, or kidney stones, thus methenamine hippurate tablets are required to treat these conditions. For instance, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations responsible for international public health, one in six individuals on the planet will be 60 or older by 2030. In 2021, there were 1.4 billion people over the age of 60. The number of persons who are 60 years or older globally will double by 2050 (2.1 billion). The number of people who are 80 years or older is projected to treble, reaching 426 million. Therefore, the increasing geriatric population is driving the growth of the methenamine hippurate tablets market.
Market Trends —
Product innovations have emerged as the key trend gaining popularity in the methenamine hippurate tablets market. Major companies operating in the methenamine hippurate tablets market are developing innovative products to strengthen their position in the market. For instance, in August 2021, Custex, a US-based urinary health brand, launched Cystex Ultra Protection. The unique features of Cystex Ultra Protection include probiotics, cranberries, vitamin A, and bio-shield technology. The Cystex Ultra Protection is intended to treat recurrent UTIs and maintain urinary tract health in more than 90% of women.
The methenamine hippurate tablets market covered in this report is segmented –
1) By Type: 20 Tablets Or Bottle, 6 Tablets Or Bottle
2) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
3) By Application: Uncomplicated UTIs, Healthcare-associated UTIs
4) By End User: Hospitals, Homecare, Specialty Clinics, Others End Users
Get an inside scoop of the methenamine hippurate tablets market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=9412&type=smp
Regional Insights —
North America was the largest region in the methenamine hippurate tablets market in 2023. The regions covered in the methenamine hippurate tablets market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Key Companies —
Major companies operating in the methenamine hippurate tablets market report are Validus Pharmaceuticals LLC, Alvogen Lux Holdings S.ÀR.L., Micro Labs Inc., Aurobindo Pharma, Edenbridge Pharmaceuticals LLC, Kreative Organics, CorePharma LLC, Amneal Pharmaceuticals Inc., Viatris Inc., County Line Pharmaceuticals, Mylan N.V., McKesson Corporation, Nuray Chemicals Private Limited, Chemische Fabrik Berg GmbH, Siegfried AG, Sun Pharmaceutical Industries Ltd., Cipla Ltd., Dr. Reddy’s Laboratories Ltd., Cadila Healthcare Ltd., Torrent Pharmaceuticals Ltd., Glenmark Pharmaceuticals Ltd., Zydus Pharmaceuticals Ltd., Lupin Ltd., Alkem Laboratories Ltd., Ipca Laboratories Ltd., Granules India Ltd., Ajanta Pharma Ltd., Teva Pharmaceutical Industries Ltd., Apotex Pharmachem Inc., Taro Pharmaceutical Industries Ltd., Sandoz International GmbH .
Table of Contents
1. Executive Summary
2. Methenamine Hippurate Tablets Market Report Structure
3. Methenamine Hippurate Tablets Market Trends And Strategies
4. Methenamine Hippurate Tablets Market — Macro Economic Scenario
5. Methenamine Hippurate Tablets Market Size And Growth
…..
27. Methenamine Hippurate Tablets Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
